Please sign in to follow a disease.

RNASEH2C-related type 1 interferonopathy

MONDO:0700258

Any type 1 interferonopathies in which the cause of the disease is a variation in the RNASEH2C gene. Individuals with variants in RNASEH2C can present with a variety of phenotypes, including Aicardi-Goutieres syndrome.

12 clinical trials for this condition and its sub-types, 0 tagged with RNASEH2C-related type 1 interferonopathy itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Hereditary disorder of connective tissue (1311) ↑ Type 1 interferonopathy (21)

Sub-types of RNASEH2C-related type 1 interferonopathy

Aicardi-Goutieres syndrome 3 0 trials

Including sub-types (12) Tagged with RNASEH2C-related type 1 interferonopathy (0)

Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

New pill aims to tame rare immune diseases

Disease control Ongoing

This early-stage trial tests an experimental drug called BI 3000202 in 16 adults with rare type 1 interferonopathies, such as Aicardi-Goutières syndrome. Participants take a low dose for 4 weeks, then a higher dose for 36 weeks. The main goal is to see if the drug is safe and how…

Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Disease control

Last updated Sep 17, 2026 00:00 UTC

RNASEH2C-related type 1 interferonopathy

Where it sits in the disease tree

New pill aims to tame rare immune diseases